152 related articles for article (PubMed ID: 38698180)
1. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.
Wang J; Yan L; Wang X; Jia R; Guo J
Inflamm Res; 2024 May; ():. PubMed ID: 38698180
[TBL] [Abstract][Full Text] [Related]
2. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
Wang X; Yan L; Guo J; Jia R
Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
[TBL] [Abstract][Full Text] [Related]
3. Modulation of
Sun J; Bai J; Jiang T; Gao Y; Hua Y
RNA Biol; 2019 Dec; 16(12):1794-1805. PubMed ID: 31441370
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.
Guo J; Che X; Wang X; Jia R
RSC Adv; 2018 Feb; 8(13):7159-7163. PubMed ID: 35540349
[TBL] [Abstract][Full Text] [Related]
5. Reversing T Cell Exhaustion by Converting Membrane PD-1 to Its Soluble form in Jurkat Cells; Applying The CRISPR/Cas9 Exon Skipping Strategy.
Yousefi-Najafabadi Z; Mehmandoostli Z; Asgari Y; Kaboli S; Falak R; Kardar GA
Cell J; 2023 Sep; 25(9):633-644. PubMed ID: 37718766
[TBL] [Abstract][Full Text] [Related]
6. Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer.
Zhu Y; Deng H; Chen X; Li H; Yang C; Li S; Pan X; Tian S; Feng S; Tan X; Matsuo M; Zhang Z
Hum Genet; 2019 Jul; 138(7):771-785. PubMed ID: 31168774
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 Exon 3 Is a Hidden Switch of Its Expression and Function in Oral Cancer Cells.
Yan L; Sun Y; Guo J; Jia R
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175900
[TBL] [Abstract][Full Text] [Related]
8. The ETFDH c.158A>G variation disrupts the balanced interplay of ESE- and ESS-binding proteins thereby causing missplicing and multiple Acyl-CoA dehydrogenation deficiency.
Olsen RK; Brøner S; Sabaratnam R; Doktor TK; Andersen HS; Bruun GH; Gahrn B; Stenbroen V; Olpin SE; Dobbie A; Gregersen N; Andresen BS
Hum Mutat; 2014 Jan; 35(1):86-95. PubMed ID: 24123825
[TBL] [Abstract][Full Text] [Related]
9. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
[TBL] [Abstract][Full Text] [Related]
10. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
[TBL] [Abstract][Full Text] [Related]
11. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
Li D; Guo J; Jia R
J Mol Biol; 2023 Mar; 435(6):167993. PubMed ID: 36736887
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA.
Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H
J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705
[TBL] [Abstract][Full Text] [Related]
14. Rescue of mis-splicing of a common
Feng P; Xu Z; Chen J; Liu M; Zhao Y; Wang D; Han L; Wang L; Wan B; Xu X; Li D; Shu Y; Hua Y
Mol Ther Nucleic Acids; 2022 Jun; 28():280-292. PubMed ID: 35433113
[TBL] [Abstract][Full Text] [Related]
15. HnRNPR strongly represses splicing of a critical exon associated with spinal muscular atrophy through binding to an exonic AU-rich element.
Jiang T; Qu R; Liu X; Hou Y; Wang L; Hua Y
J Med Genet; 2023 Nov; 60(11):1105-1115. PubMed ID: 37225410
[TBL] [Abstract][Full Text] [Related]
16. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
[TBL] [Abstract][Full Text] [Related]
17. Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element.
Dal Mas A; Fortugno P; Donadon I; Levati L; Castiglia D; Pagani F
Hum Mutat; 2015 May; 36(5):504-12. PubMed ID: 25665175
[TBL] [Abstract][Full Text] [Related]
18. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.
Nasrin F; Rahman MA; Masuda A; Ohe K; Takeda J; Ohno K
Sci Rep; 2014 Oct; 4():6841. PubMed ID: 25354590
[TBL] [Abstract][Full Text] [Related]
19. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
Kashima T; Rao N; David CJ; Manley JL
Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
[TBL] [Abstract][Full Text] [Related]
20. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.
Goina E; Skoko N; Pagani F
Mol Cell Biol; 2008 Jun; 28(11):3850-60. PubMed ID: 18391021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
